Pai A - Search Results

1

Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease.

Raj DS, Dominic EA, Pai A, Osman F, Morgan M, Pickett G, Shah VO, Ferrando A, Moseley P. Raj DS, et al. Among authors: pai a. Kidney Int. 2005 Nov;68(5):2338-44. doi: 10.1111/j.1523-1755.2005.00695.x. Kidney Int. 2005. PMID: 16221238 Free article.

2

Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.

Pai AB, Norenberg J, Boyd A, Raj D, Chan LN. Pai AB, et al. Clin Ther. 2007 Dec;29(12):2699-705. doi: 10.1016/j.clinthera.2007.12.024. Clin Ther. 2007. PMID: 18201586 Clinical Trial.

3

Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.

Pai AB, Boyd AV, McQuade CR, Harford A, Norenberg JP, Zager PG. Pai AB, et al. Pharmacotherapy. 2007 Mar;27(3):343-50. doi: 10.1592/phco.27.3.343. Pharmacotherapy. 2007. PMID: 17316146 Clinical Trial.

4

Sampling for international normalized ratios in patients on hemodialysis with central venous catheters.

Boyd A, Dunne A, Townsend K, Pai AB. Boyd A, et al. Among authors: pai ab. Nephrol Nurs J. 2006 Jul-Aug;33(4):408-11. Nephrol Nurs J. 2006. PMID: 17001998

5

Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects.

Pai AB, Nielsen JC, Kausz A, Miller P, Owen JS. Pai AB, et al. Clin Pharmacol Ther. 2010 Aug;88(2):237-42. doi: 10.1038/clpt.2010.80. Epub 2010 Jun 30. Clin Pharmacol Ther. 2010. PMID: 20592725 Clinical Trial.

6

Evaluating plasma pharmacokinetics of intravenous iron formulations: judging books by their covers?

Pai AB. Pai AB. Clin Pharmacokinet. 2015 Apr;54(4):323-4. doi: 10.1007/s40262-014-0218-2. Clin Pharmacokinet. 2015. PMID: 25445844 No abstract available.

7

Pai AB, Boyd A, Chavez A, Manley HJ. Pai AB, et al. Hemodial Int. 2009 Jan;13(1):72-9. doi: 10.1111/j.1542-4758.2009.00328.x. Hemodial Int. 2009. PMID: 19210281 Clinical Trial.

8

Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival.

Gupta A, Zhuo J, Zha J, Reddy S, Olp J, Pai A. Gupta A, et al. Among authors: pai a. BMC Nephrol. 2010 Aug 17;11:16. doi: 10.1186/1471-2369-11-16. BMC Nephrol. 2010. PMID: 20716362 Free PMC article.

9

Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach.

Pai AB, Cardone KE, Manley HJ, St Peter WL, Shaffer R, Somers M, Mehrotra R; Dialysis Advisory Group of American Society of Nephrology. Pai AB, et al. Clin J Am Soc Nephrol. 2013 Nov;8(11):1988-99. doi: 10.2215/CJN.01420213. Epub 2013 Aug 29. Clin J Am Soc Nephrol. 2013. PMID: 23990162 Free PMC article.

10

Iron Oxide Nanoparticle Formulations for Supplementation.

Pai AB. Pai AB. Met Ions Life Sci. 2019 Jan 14;19:/books/9783110527872/9783110527872-012/9783110527872-012.xml. doi: 10.1515/9783110527872-012. Met Ions Life Sci. 2019. PMID: 30855107 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters